DocumentJDRF Therapeutic Venturesîncărcat de
sstrumello7395- DocumentGeneral Foods Corporate Timelineîncărcat desstrumello7395
- DocumentJDRF, Less Until Noneîncărcat desstrumello7395
- DocumentWhy Big Pharmaceutical Companies’ Current Nanotech Efforts Should Failîncărcat desstrumello7395
- DocumentNovo Nordisk Congressional Testimony on Follow-On Biopharmaceuticals Mollerup March 26, 2007încărcat desstrumello7395
- DocumentEmblem Insulin Formulary Change 2010încărcat desstrumello7395
- DocumentWhy Nonprofits Fund For-Profit Companies Doing Drug Researchîncărcat desstrumello7395
- DocumentAgaMatrix & Sanofi-Aventis Enter Global Diabetes Partnershipîncărcat desstrumello7395
- DocumentHuman insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptorsîncărcat desstrumello7395
- DocumentFDA ISO Standards for BG Meters 06-24-2009încărcat desstrumello7395
- DocumentBeyond 'I'm a Diabetic', Little Common Groundîncărcat desstrumello7395
- DocumentHalozyme Therapeutics, Inc. 2009 Investor Day Presentationîncărcat desstrumello7395
- DocumentJDRF Countdown July 2009încărcat desstrumello7395
- Document2008-03-24_Asset_EN Paper on Follow-On Biologics Jan. 2007încărcat desstrumello7395
- Document2008-03-24_Asset_PCMA Summary of en Studyîncărcat desstrumello7395
- DocumentInfluence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabeticsîncărcat desstrumello7395
- DocumentThe Unique Cytoarchitechture of Human Pancreatic Islets Has Implications for Islet Cell Functionîncărcat desstrumello7395
- DocumentStatement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings on "Follow-On Biopharmaceuticals"încărcat desstrumello7395
- DocumentMost Commercial Insulin Assays Fail to Detect Recombinant Insulin Analoguesîncărcat desstrumello7395
- DocumentHow Do We Define Cure of Diabetes?încărcat desstrumello7395
- DocumentExpanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin isotopeîncărcat desstrumello7395
- DocumentCould Generic Insulin Soon Hit the U.S. Market?încărcat desstrumello7395
- DocumentClass Action Complaint for Negligence, Products Liability and Punitive Damages Against Eli Lilly & Company and Novo Nordisk A/S Re; Biosynthetic Human Insulinîncărcat desstrumello7395
- DocumentMandated Diabetes Registries Will Not Benefit Persons With Diabetesîncărcat desstrumello7395
- DocumentDetermination of Purity and Identification of Animal Sources of Insulin in Various Insulin Preparationsîncărcat desstrumello7395
- DocumentPeter Van Etten JDRF Letter Reîncărcat desstrumello7395
- DocumentTreatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsîncărcat desstrumello7395
- DocumentDifferent Potencies of Biosynthetic Human and Purified Porcine Insulinîncărcat desstrumello7395
- DocumentQuestions Answers &încărcat desstrumello7395
- DocumentStem Cells and Diabetesîncărcat desstrumello7395
- DocumentFederal Funding of Stem Cell Researchîncărcat desstrumello7395
Documente Academic
Documente Profesional
Documente Cultură
